Tumor-infiltrating lymphocytes (TILs), interferon γ (IFN-γ), programmed cell death ligand-1 (PD-L1), and human leukocyte antigen-I (HLA-I) have also been regarded as predictive markers of immunotherapy. This evidence concerns the gene CD274 and neoplasm.